BVS Q2 2025 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

Q2 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$148M-2.4% YoY

Gross Profit

$102M69.1% margin

Operating Income

$18M12.4% margin

Net Income

$7M5.1% margin

EPS (Diluted)

$0.11

QoQ Revenue Growth

+19.2%

Cash Flow

Operating Cash Flow

$26M

Free Cash Flow

$25M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$707M

Total Liabilities

$505M

Stockholders' Equity

$161M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$148M	$151M	-2.4%
Gross Profit	$102M	$104M	-1.5%
Operating Income	$18M	-$31M	+158.4%
Net Income	$7M	-$26M	+129.0%

Revenue Segments

U.S. Segment

$129M87%

International Segment

$19M13%

Geographic Segments

UNITED STATES

$129M87%

Non-US

$19M13%